Bumetanide has a more favourable effect on insulin resistance than furosemide in patients with heart failure - a pilot study
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 26 Mar 2014
At a glance
- Drugs Bumetanide (Primary) ; Furosemide (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 13 Dec 2010 Planned end date changed from 1 Dec 2010 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 01 Aug 2008 The expected completion date for this trial is now 1 Dec 2010.